BNP Paribas Financial Markets’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-52,312
Closed -$199K 3764
2020
Q1
$199K Buy
52,312
+32,904
+170% +$125K ﹤0.01% 2268
2019
Q4
$98.8K Buy
19,408
+5,941
+44% +$30.2K ﹤0.01% 2641
2019
Q3
$68.1K Buy
13,467
+4,142
+44% +$20.9K ﹤0.01% 2698
2019
Q2
$57.5K Sell
9,325
-8,231
-47% -$50.8K ﹤0.01% 2724
2019
Q1
$81.5K Buy
17,556
+17,529
+64,922% +$81.3K ﹤0.01% 2661
2018
Q4
$113 Sell
27
-2,521
-99% -$10.6K ﹤0.01% 3490
2018
Q3
$16K Hold
2,548
﹤0.01% 2842
2018
Q2
$20.5K Sell
2,548
-20,674
-89% -$166K ﹤0.01% 2838
2018
Q1
$173K Sell
23,222
-5,891
-20% -$43.9K ﹤0.01% 2320
2017
Q4
$173K Sell
29,113
-6,210
-18% -$36.9K ﹤0.01% 2388
2017
Q3
$260K Buy
35,323
+14,758
+72% +$109K ﹤0.01% 2052
2017
Q2
$140K Buy
20,565
+7,604
+59% +$51.6K ﹤0.01% 2262
2017
Q1
$122K Buy
12,961
+11,860
+1,077% +$112K ﹤0.01% 2049
2016
Q4
$9.51K Sell
1,101
-3,608
-77% -$31.2K ﹤0.01% 2924
2016
Q3
$29.8K Buy
4,709
+2,150
+84% +$13.6K ﹤0.01% 2676
2016
Q2
$10.8K Buy
+2,559
New +$10.8K ﹤0.01% 2878
2016
Q1
Sell
-15,354
Closed -$94.1K 3282
2015
Q4
$94.1K Buy
15,354
+955
+7% +$5.85K ﹤0.01% 2372
2015
Q3
$82.4K Buy
14,399
+8,605
+149% +$49.2K ﹤0.01% 2510
2015
Q2
$43.2K Buy
5,794
+4,141
+251% +$30.9K ﹤0.01% 2581
2015
Q1
$9.89K Buy
+1,653
New +$9.89K ﹤0.01% 2751
2014
Q4
Sell
-4,023
Closed -$20.9K 3075
2014
Q3
$20.9K Buy
+4,023
New +$20.9K ﹤0.01% 2674
2014
Q2
Sell
-156
Closed -$551 3496
2014
Q1
$551 Sell
156
-616
-80% -$2.18K ﹤0.01% 2574
2013
Q4
$4.12K Sell
772
-14,883
-95% -$79.3K ﹤0.01% 2737
2013
Q3
$78.6K Sell
15,655
-2,581
-14% -$13K ﹤0.01% 2135
2013
Q2
$81.3K Buy
+18,236
New +$81.3K ﹤0.01% 2257